Spokane, WANCT06602193Now EnrollingIRB Ready

Parkinson's Disease Clinical Trial in Spokane, WA

Access cutting-edge parkinson's disease treatment through this clinical trial at a research site in Spokane. Study-provided care at no cost to qualified participants.

Sponsored by Denali Therapeutics Inc.

Quick Self-Assessment

See if you qualify for this Spokane location

Preparing your pre-screening questions...

Expert Care in Spokane

Access parkinson's disease specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related parkinson's disease treatment provided free

Apply for This Spokane Location

Check if you qualify for this parkinson's disease clinical trial in Spokane, WA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Spokane

    Convenient for WA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Spokane site if eligible
  4. 4Begin participation

About This Parkinson's Disease Study in Spokane

This Phase 2a, multicenter, randomized, 12-week double-blind, placebo-controlled, parallel-group study, followed by an OLE, is designed to evaluate the safety, tolerability, and pharmacodynamic effects of BIIB122 in participants with LRRK2-PD. LRRK2-PD is defined as Parkinson's Disease (PD) in individuals who are heterozygous or homozygous carriers of a pathogenic LRRK2 variant that increases LRRK2 kinase activity.

Sponsor: Denali Therapeutics Inc.

Who Can Participate

Inclusion Criteria

For heterozygous pathogenic LRRK2 mutation carriers: ≥ 30 to ≤ 80 years
For homozygous pathogenic LRRK2 mutation carriers: ≥ 30 years
Have screening genetic test results verifying the presence of a pathogenic LRRK2 variant.
Have a clinical diagnosis of PD meeting the Movement Disorder Society Clinical Diagnostic Criteria.

Exclusion Criteria

Have a history of any clinically significant neurological disorder other than PD, including, but not limited to, stroke and dementia, in the opinion of the investigator, within 5 years of the screening visit.
Have clinical evidence of atypical parkinsonism (eg, multiple-system atrophy or progressive supranuclear palsy) or evidence of drug-induced parkinsonism.
Have previously participated or are currently participating in the BIIB122 LUMA study (Study 283PD201).
Have previously participated or are currently participating in a gene therapy study for PD.
Have a history of brain surgical intervention for PD (eg

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Spokane?

Yes, this clinical trial (NCT06602193) has an active research site in Spokane, WA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Parkinson's Disease Treatment Options in Spokane, WA

If you're searching for parkinson's disease treatment options in Spokane, WA, this clinical trial (NCT06602193) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Spokane research site is actively enrolling participants for this clinical trial. You'll receive care from experienced parkinson's disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all parkinson's disease clinical trials near you to find additional studies recruiting in your area.

More Parkinsons Disease Trials in Spokane, WA

See all parkinsons disease clinical trials recruiting in Spokane — not just this study.

Browse Parkinsons Disease Trials in Spokane →

Browse More Trials by Condition

Parkinsons Disease TrialsAnkylosing Spondylitis TrialsAll Conditions →

Ready to Join in Spokane?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Spokane, WA